Skip to main content
. 2008 Aug;49(8):1658–1669. doi: 10.1194/jlr.M800046-JLR200

Fig. 2.

Fig. 2.

A: Adiponectin levels in lean and obese mice. Vehicle or vehicle containing L-4F was administered daily for 6 weeks (as described in Materials and Methods), and serum samples were obtained immediately prior to euthanization. The results are expressed as μg/ml serum. *P < 0.027 vehicle-treated lean versus vehicle-treated obese mice; #P < 0.04 L-4F-treated obese versus vehicle-treated obese mice. B, C: Serum IL-1β and IL-6 levels in lean and obese mice. Vehicle or vehicle containing L-4F was administered as described in Materials and Methods. Serum samples were obtained immediately prior to euthanization. B:The results for lean vehicle-treated or obese L-4F-treated versus obese vehicle-treated mice for IL-1β; *P < 0.02 vehicle-treated obese versus vehicle-treated lean mice; #P < 0.05 L-4F-treated obese versus vehicle-treated obese mice. C: The results for lean vehicle-treated or obese L-4F-treated versus obese vehicle-treated mice for IL-6; *P < 0.05 vehicle-treated obese versus vehicle-treated lean mice; #P < 0.05 L-4F-treated obese versus vehicle-treated obese mice. Results are shown as the mean ± SEM.